Exhibit 12
Biomet, Inc.
Computation of Ratio of Earnings to Fixed Charges
(In millions, except ratios)
| (3) Successor |
Predecessor | ||||||||||||||||||||||||||||
| Period from June 1, 2007 through July 11, 2007 |
Years Ended May 31, | ||||||||||||||||||||||||||||
| Pro Forma Period from July 11, 2007 through February 29, 2008 |
(3) Pro Forma 2007 |
2007 | 2006 | 2005 | 2004 | 2003 | |||||||||||||||||||||||
| Earnings: |
|||||||||||||||||||||||||||||
| Earnings (loss) before income taxes |
$ | (430.4 | ) | $ | (81.9 | ) | $ | (477.9 | ) | $ | 501.6 | $ | 611.0 | $ | 546.5 | $ | 500.7 | $ | 451.7 | ||||||||||
| Add: Fixed charges (per below) |
438.3 | 0.3 | 593.6 | 9.3 | 11.7 | 9.2 | 4.2 | 4.4 | |||||||||||||||||||||
| Total earnings (loss) |
$ | 7.9 | (1) | $ | (81.6 | ) | $ | 115.7 | $ | 510.9 | $ | 622.7 | $ | 555.7 | $ | 504.9 | $ | 456.1 | |||||||||||
| Fixed charges: |
|||||||||||||||||||||||||||||
| Interest expense |
$ | 438.3 | $ | 0.3 | $ | 593.6 | $ | 9.3 | $ | 11.7 | $ | 9.2 | $ | 4.2 | $ | 4.4 | |||||||||||||
| Amortization of bond premium |
0.3 | — | — | — | — | — | — | — | |||||||||||||||||||||
| Total fixed charges |
$ | 438.3 | $ | 0.3 | $ | 593.6 | $ | 9.3 | $ | 11.7 | $ | 9.2 | $ | 4.2 | $ | 4.4 | |||||||||||||
| Ratio of earnings to fixed charges |
N/A | (2) | N/A | (1) | N/A | (1) | 54.9 | 53.2 | 60.4 | 120.2 | 103.7 | ||||||||||||||||||
| (1) | After adjustments required by Item 503(d) of SEC Regulation S-K |
| (2) | On a pro forma basis, earnings were inadequate to cover fixed charges for fiscal 2007, and the period from July 12, 2007 through February 29, 2008 by $477.9 million and $430.4 million, respectively. Earnings were also inadequate to cover fixed charges for the period from June 1, 2007 through July 11, 2007 by $81.9 million. |
| (3) | Numbers are Pro Forma'd as required by Item 503(d), 2. (B), of SEC Regulation S-K. |